Announcements Trials

Browse Landscape

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 10 Ovarian Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 3 Lung Neoplasms 3 Carcinoma, Ovarian Epithelial 3 Carcinoma, Non-Small-Cell Lung 3 Urinary Bladder Neoplasms 2 Rectal Neoplasms 2 Melanoma 2 Liver Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Hepatocellular 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Tobacco Use Disorder 1 Recurrence 1 Precancerous Conditions 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Oligodendroglioma 1 Neoplasms 1 Neoplasm Metastasis 1 Kidney Neoplasms 1 Hirschsprung Disease 1 Glioma 1 Ganglion Cysts 1 Gallbladder Neoplasms 1 Endometrial Neoplasms 1

Interventions

Fluorouracil 18 Oxaliplatin 17 Capecitabine 16 Leucovorin 13 Cisplatin 12 Gemcitabine 11 Drug Therapy 11 Irinotecan 10 Radiosurgery 9 Cetuximab 9 Bevacizumab 9 pembrolizumab 8 Docetaxel 8 Everolimus 7 spartalizumab 6 Sunitinib 6 Radiotherapy 6 Paclitaxel 6 Neoadjuvant Therapy 6 Cyclophosphamide 6 Trastuzumab 5 S 1 (combination) 5 Nivolumab 5 Immunotherapy 5 Immune Checkpoint Inhibitors 5 Chemotherapy, Adjuvant 5 Carboplatin 5 palbociclib 4 manganese chloride 4 Surgical Procedures, Operative 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Neoplasm Metastasis × Immunohistochemistry × Clear all

NCT02353988 2015-02-03

Arbre

Jinling Hospital, China

Phase 2 Unknown

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡